Skip to main content
. Author manuscript; available in PMC: 2023 Oct 3.
Published in final edited form as: Clin Cancer Res. 2023 Apr 3;29(7):1232–1242. doi: 10.1158/1078-0432.CCR-22-1973

Figure 3. 89Zr-4A06 PET detects molecularly diverse human BC xenografts with varying levels of CDCP1 expression.

Figure 3.

A. Representative coronal and transverse PET/CT images acquired 72 hours post injection of 89Zr-4A06. The position of the tumor is indicated with an orange arrow. B. Ex vivo tumor uptake data acquired 72 hours post injection of 89Zr-4A06 (n = 5 mice/tumor). C. Tumor to muscle ratios calculated from postmortem biodistribution data collected 72 hours post injection.